The case for investing in healthcare startups
Despite their immense potential and positive impact, such startups struggle to attract funding
SINGAPORE has seen significant growth in the number of startups and investments in the healthcare technology sector. Last year, Singapore’s healthtech startups raised US$409 million, with deal volume doubling from the previous year.
Across the globe, countries grapple with ageing populations, rising chronic disease burdens, and increasing healthcare costs. Conventional healthcare systems struggle to meet these demands – leaving room for startups that offer more efficient, cost-effective and patient-centric solutions.
Such startups harness innovations to tackle problems in traditional healthcare systems, improving patient outcomes, widening access and enhancing quality of care.
TRENDING NOW
Knight Frank Singapore CEO Galven Tan resigns after 2.5 years at helm
ABSD deadline extended to up to 7 years for developers of large en bloc sites to encourage reuse of land
15-month wait-out curb lifted for private property owners buying HDB resale flats
Philippines’ income upgrade hides grim reality for most Filipinos